PM-CELL

Development of a rapid cellular characterisation technology for use in the biopharmaceutical Industry

Coordinatore	TECHNO-PATH DISTRIBUTION    more  Organization address address: FORTHENRY BUSINESS PARK city: BALLINA contact info Titolo: Dr. Nome: Guy Cognome: Mozolowski Email: send email Telefono: 35361335844
Nazionalità Coordinatore	Ireland [IE]
Totale costo	1˙497˙561 €
EC contributo	1˙133˙099 €
Programma	FP7-SME Specific Programme "Capacities": Research for the benefit of SMEs
Code Call	FP7-SME-2011
Funding Scheme	BSG-SME
Anno di inizio	2011
Periodo (anno-mese-giorno)	2011-09-01   -   2013-11-30

 Partecipanti

#	participant	country	role	EC contrib. [€]
1	TECHNO-PATH DISTRIBUTION  Organization address address: FORTHENRY BUSINESS PARK city: BALLINA contact info Titolo: Dr. Nome: Guy Cognome: Mozolowski Email: send email Telefono: 35361335844	IE (BALLINA)	coordinator	499˙999.38
2	IUL INSTRUMENTS GMBH  Organization address address: KOENINGSWINTERER STR. 409 A city: KOENINGSWINTER postcode: 53639 contact info Titolo: Mr. Nome: Alexander Cognome: Beljaars Email: send email Telefono: +49 2223 91920 Fax: +49 2223 9192 48	DE (KOENINGSWINTER)	participant	413˙874.53
3	EUFORMATICS OY  Organization address address: KUNINKAATIE 6A city: ESPOO postcode: 2740 contact info Titolo: Dr. Nome: Christophe Cognome: Roos Email: send email Telefono: +358 50 5326029	FI (ESPOO)	participant	95˙603.50
4	INSTITUTE OF TECHNOLOGY TRALEE  Organization address address: CLASH city: TRALEE contact info Titolo: Dr. Nome: Joanna Cognome: Tierney Email: send email Telefono: 353667000000 Fax: 353667000000	IE (TRALEE)	participant	56˙356.83
5	DORTE EGELUND APS  Organization address address: RINGSTEDGADE 25 city: ROSKILDE postcode: 4000 contact info Titolo: Ms. Nome: Dorte Cognome: Egelund Email: send email Telefono: +45 4020 2576	DK (ROSKILDE)	participant	54˙465.25
6	THE UNIVERSITY OF SHEFFIELD  Organization address address: FIRTH COURT WESTERN BANK city: SHEFFIELD postcode: S10 2TN contact info Titolo: Ms. Nome: Joanne Cognome: Watson Email: send email Telefono: +44 114 2224754	UK (SHEFFIELD)	participant	6˙000.00
7	UNIVERSITY OF LIMERICK  Organization address address: NATIONAL TECHNOLOGICAL PARK, PLASSEY city: LIMERICK postcode: - contact info Titolo: Prof. Nome: Gary Cognome: Walsh Email: send email Telefono: +353 61 202664 Fax: +353 61 202568	IE (LIMERICK)	participant	3˙600.00
8	THE SECRETARY OF STATE FOR ENVIRONMENT, FOOD AND RURAL AFFAIRS  Organization address address: Area 1A, Nobel House, Smith Square 17 city: LONDON postcode: SW1P 3JR contact info Titolo: Dr. Nome: William Cognome: Newell Email: send email Telefono: +44 1932 357774	UK (LONDON)	participant	3˙200.00

Mappa

 Word cloud

Esplora la "nuvola delle parole (Word Cloud) per avere un'idea di massima del progetto.

 Obiettivo del progetto (Objective)

'Biopharmaceuticals have universal importance as effective therapeutics for many human diseases. Biopharmaceutical production employs living cells as ‘production machinery’ with the selection of the producing cell line, a critical step for an efficient industrial process. Current industry practices for cell selection are expensive and time-consuming. The proposed PM-CELL project will result in the development of a rapid cellular characterisation testing technology. The two-year project will result in an innovative 96-well micro-titre plate containing a unique array of analytes, which can be used to accelerate development and reduce manufacturing costs of biopharmaceuticals synthesised by mammalian cell lines. A successful project would result in cost savings for the SMEs’ customers in the bioprocessing industry and a more rapid translation of research to efficient drug production for human healthcare. The project would result in generation of a high value (economic and intellectual property) technology which would result in increased sales and assets to the SMEs. The SMES will then be well placed to take advantage of further development opportunities in the biopharmaceutical industry, which is actively looking for innovative solutions for manufacturing-cell selection in drug production.'

Introduzione (Teaser)

Expediting pharmaceutical development processes could significantly speed up the time taken for a product to reach the market. A European consortium working towards the development of a cell screening prototype that could be incorporated in various biopharmaceutical processes.